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Abstract
This paper compares the correlation between the clinical signs and the histopathological observations of the entire intestine in cats and 
dogs with inflammatory bowel disease (IBD). To perform this study, hospital records of 53 dogs and 20 cats of different sex, ages, and breed 
diagnosed with IBD following the histopathological criteria of the World Small Animal Veterinary Association (WSAVA) were evaluated. The 
results obtained in this study did show correlations between some clinical signs and the histopathological assessment of dogs and cats with 
IBD. Therefore, a slight association between diarrhea and lacteal dilation in the small bowel, and diarrhea and desquamation in the large 
bowel of dogs with IBD was seen, but no other associations were found between the rest of the lesions and symptoms. In contrast, cats only 
showed a correlation between anorexia with villous stunting and villous epithelial injury, without correspondence among other clinical signs 
and lesions. The results of this study propose that the evaluation of IBD can be complicated, especially with the use of retrospective records 
of archived intestinal biopsies and subjective clinical and histopathologic decisions.
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İnflamatuar Bağırsak Hastalığı Olan Kedi ve Köpeklerde Klinik Bulgular İle 
Patolojik Bulgular Arasındaki İlişkilerin Araştırılması
Öz
Bu makale, inflamatuar bağırsak hastalığı (IBD) olan kedi ve köpeklerde bütün bağırsakların klinik bulguları ile histopatolojik gözlemleri 
arasındaki korelasyonu karşılaştırmaktadır. Bu çalışmayı gerçekleştirmek için, World Small Animal Veterinary Association (WSAVA)’in 
histopatolojik kriterlerini izleyerek IBD tanısı konan farklı cinsiyet, yaş ve ırkta 53 köpek ve 20 kedinin hastane kayıtları değerlendirildi. Bu 
çalışmada elde edilen sonuçlar, IBD’li köpek ve kedilerde bazı klinik bulgular ile  histopatolojik bulgular arasında korelasyon olduğunu 
gösterdi. Bu nedenle, IBD’li köpeklerde ince bağırsakta ishal ve lakteal dilatasyon ile kalın bağırsakta ishal ve deskuamasyon arasında hafif 
bir ilişki görülmüştür, ancak lezyonların geri kalanı ve semptomlar arasında başka bir ilişki bulunmamıştır. Buna karşın, kedilerde diğer klinik 
bulgular ve lezyonlar arasında ilişki saptanmezken, sadece anoreksi ile villöz gelişim eksikliği ve villöz epitel hasar arasında bir korelasyon 
vardı. Bu çalışmanın sonuçları, özellikle intestinal biyopsilerinin arşivlenmiş retrospektif kayıtlarının subjektif klinik ve histopatolojik 
kararlarının kullanılması ile IBD değerlendirmesinin karmaşık olabileceğini düşündürmektedir.
Anahtar sözcükler: Köpek, Kedi, İnflamatuar Bağırsak Hastalığı, IBD, Lezyon, Klinik bulgu
INTRODUCTION
Inflammatory bowel disease (IBD) refers to a chronic gastro- 
intestinal (GI) disease of unknown cause and ill-defined 
pathogenesis [1]. It is characterized by persistent or recurrent 
GI signs with inflammatory infiltration of the mucous 
membrane in the lamina propria area [2-6]. The etiology 
of this process is multifactorial and may be produced by 
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inappropriate and uncontrolled inflammation of gut- 
associated lymphoid tissue against harmless environmental 
antigens [7]. Clinical signs are highly variable [1], and these 
go from diarrhea and vomiting to appetite disturbance 
such as anorexia or polyphagia. Nonetheless, the lack 
of clinical, diagnostic, histopathologic, and therapeutic 
standards resulted in great challenges that led to the 
design of specific indexes [8-11], which did not support a 
correlation between the severity of clinical signs and histo-
pathological score since findings interpretation varied 
widely between pathologists [12-15]. Despite this fact, the 
numeric index generated by some of these methods has 
been used to help clinicians and researchers to correlate 
inflammatory lesions with clinical signs [1]. Thus, Jergens et 
al.[1] proposed a set of assessment criteria called the Canine 
Inflammatory Bowel Disease Activity Index (CIBDAI). The 
suitability of this index as a monitoring tool was determined 
by the correlation between the clinical index and the 
histopathological lesions. Interestingly, a study suggested 
that the histopathological criteria for the diagnosis of GI 
tract inflammation in dogs and cats could be inconsistent [10]. 
Due to these concerns, the World Small Animal Veterinary 
Association (WSAVA) Gastrointestinal Standardization 
group developed a simplified histopathologic monograph 
that pictorially and textually defined inflammatory and 
morphologic features in endoscopic biopsy specimens 
obtained from the stomach, duodenum, and colon [10]. 
However, due to the particular individuality of IBD, only 
a sparse number of reports defining the severity of 
clinical signs in dogs with IBD and its relation with histo-
pathological lesions have been published [13,15,16]. Therefore, 
this study aimed to compare the correlation between 
histopathological changes and clinical signs in dogs and 
cats affected with IBD.
MATERIAL and METHODS
This retrospective study included hospital records of 53 dogs 
and 20 cats of different sex, ages, and breed diagnosed 
with IBD in the Small Animal Hospital of Las Palmas de Gran 
Canaria University and the Veterinary Hospital of Cordoba 
University. The study was performed from April 2016 
to August 2018 following the approval of the Ethical 
Commission of Veterinary Medicine of Las Palmas de Gran 
Canaria University (agreement MV-2017/05). Criteria for 
animal selection were: clinical signs consistent with IBD such 
as anorexia, vomiting, diarrhea and weight loss (>3 weeks 
in duration), failure to respond to dietary (a commercially 
prepared select antigen or homemade diets) or symptomatic 
therapies alone, exclusion of other causes such as exocrine 
pancreatic insufficiency, infectious agents, endoparasites, 
neoplasia or food, and antibiotic responsive enteropathies; 
and histopathologic evidence of mucosal inflammation 
in biopsy specimens. The diagnostic evaluation in all 
animals with IBD consisted of medical records taken over 
1 or more clinical examinations, hematological and serum 
biochemistry analyses, urinalysis, fecal test for parasites, 
diagnostic imaging, and histopathologic examination of GI 
mucosal biopsy specimens following the histopathologic 
scoring system of the WSAVA. 
Seven dogs and four cats that were free of gastrointestinal 
signs over one or more clinical examinations, and showed 
normal hematological and serum biochemistry analyses, 
as well as free of parasites on fecal examinations, were 
used as a control group (Table 1). Mucosal biopsies of the 
gut were also obtained from these animals as previously 
described in other studies [8,12].
Clinical Disease Activity Data
To evaluate the clinical disease activity, a retrospective 
assessment was performed following symptoms of the 
upper gastrointestinal part such as vomiting, diarrhea, 
anorexia (as appetite disorders) and weight loss, as well 
as symptoms of lower gastrointestinal signs such as 
hematochezia and mucoid feces. 
Table 1. Tissues sampled from small and large bowel of healthy dogs and cats
Sampling Location LD CD VEI SQ VS MF IEL LPI
Duodenum (1)  +  -  +  +  -  - + +
Duodenum (1)  +  +  +  +  -  + + +
Duodenum (1)  +  -  -  -  -  + + +
Duodenum (1)  +  -  -  +  -  + + +
Colon (1)  + + + + +  + + +
Colon (1)  -  - + +  -  + + +
Cecum (1)  +  - - - - + + +
Duodenum (2)  +  +  -  -  -  - - -
Duodenum (2)  -  -  -  -  -  + - -
Duodenum (2)  +  -  -  -  -  + - -
Colon (2)  -  -  -  +  -  + - -
(1) Dog. (2) Cat. LD: Lacteal dilation; CD: Crypt dystention; VEI: Villous Epithelial Injury; SQ: desquamation; VS: Villous stunting; MF: Mucosal fibrosis; 
IEL: Intraepithelial lymphocytes; LPI: Lamina propria infiltrate
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Histopathologic Examination 
To perform the histopathological assessment, biopsy 
samples from the small and large bowel of diseased 
animals were used. These samples were fixed in 10% 
neutral-buffered formalin, dehydrated through graded 
alcohols, and embedded in paraffin wax. Sections (4 µm 
thick) were cut and stained with hematoxylin and eosin 
stain for histopathological examination. It was based on 
the morphological and inflammatory findings identified 
in the standard histopathologic system of the WSAVA 
Gastrointestinal Standardization group [12], as well as on 
those modifications done by Jergens et al.[10]. Therefore, 
for small and large bowel samples the main morphological 
features chosen were villous stunting, epithelial injury, 
crypt distention, lacteal dilation, desquamation, mucosal 
fibrosis, as well as intraepithelial lymphocyte and lamina 
propria infiltration. Clinical data and specific histopathological 
lesions were used and compared to search for significant 
associations. 
Statistical Analysis
The lesions and clinical signs of the animals involved in 
this research were categorical variables summarized as 
frequencies and percentages. These percentages were 
compared using the Chi-square test. Statistical significance 
was set at P<0.05. The values in duodenum-jejunum-
ileum as small intestine, and cecum-colon-rectum as 
large intestine were fused in order to check accurately 
the correlations between clinical signs and pathological 
findings of animals with IBD.
RESULTS
Histopathological lesions and clinical signs of 53 dogs and 
20 cats of different breed and sex with IBD are shown in 
Table 2 and Table 3 (dogs), and Table 4 and Table 5 (cats). 
The location-based on histopathologic lesions present in 
biopsy of dog specimens was as follows: upper intestinal 
part (n=27 cases) that included duodenum (n=24 cases), 
jejunum (n=2 cases) and ileum (n=1 case); and lower 
intestinal part (n=26 cases), with cecum (n=2), colon (n=17 
cases), and rectum (n=7 cases). These patients showed 
highly variable histopathological lesions. Therefore, according 
to WSAVA guidelines, lacteal dilation was found in 37 out 
of 53 animals, crypt distention in 28 out of 53 animals, 24 
animals showed villous epithelial injury, desquamation 
was found in 23 out of 53 animals, villous stunting just 
in 14 animals, and mucosal fibrosis in 35 animals in total 
(Fig. 1. a-d).
In case of cats, the distribution on histopathologic lesions 
present in biopsy specimens was as follows: upper intestinal 
part (n=14 cases) that included duodenum (n=14 cases); 
and lower intestinal part (n=6 cases), where only colon 
lesions (n=6 cases) were detected. Among these cases 
lacteal dilation was identified in 12 out of 20 cats, crypt 
Table 2. Histopathologic assesment of small and large bowel of dogs with IBD
Intestine LD CD VEI SQ VS MF IEL LPI
Small bowel (n: 27) 20 14 12 11 7 16 26 27
Duodenum (24) 17 12 11 10 6 14 23 24
Jejenum (2) 2 1 - - 1 2 2
Ileum (1) 1 1 1 1 1 1 1 1
Large Bowel (n: 26) 17 14 12 12 7 19 26 26
Colon (17) 12 12 10 11 6 15 20 20
Rectum (7) 4 2 2 1 1 3 5 5
Cecum (2) 1 - - - - 1 1 1
LD: Lacteal dilation; CD: Crypt dystention; VEI: Villous Epithelial Injury; SQ: desquamation; VS: Villous stunting; MF: Mucosal fibrosis; IEL: Intraepithelial 
lymphocytes; LPI: Lamina propria infiltrate
Table 3. Relation between samples and clinical signs in small and large bowel of IBD dogs
Intestine Vomiting Diarrhea Anorexia Weight Loss Hematochezia Mucoid Feces
Small bowel (n: 27) 16 21 7 7 1 -
Duodenum (24) 14 18 7 7 1 -
Jejenum (2) 2 2 - - - -
Ileum (1) - 1 - - - -
Large Bowel (n: 26) 7 21 1 2 15 11
Colon (17) 5 17 1 1 11 10
Rectum (7) 1 3 - 1 4 1
Cecum (2) 1 1 - - - -
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distension was found in 14 out of 20 animals, 8 cats showed 
villous epithelial injury, desquamation was found in 10 
out of 20 animals, whereas villous stunting and mucosal 
fibrosis were identified in 3 and 17 cats, respectively.
The cellular infiltrate in all mucosal specimens was pre-
dominantly composed of lymphocytes and plasma cells, 
sometimes accompanied by an admixture of sparse 
numbers of eosinophils, neutrophils, and macrophages. 
Lymphocyte infiltration in the duodenum of animals with 
IBD was significantly increased compared with controls, 
and these were mainly located in the upper part of the 
villi, as well as within the epithelial layer. In contrast, in 
the colonic mucosa, there was smaller variability between 
control individuals and animals with IBD. 
The statistical analysis revealed a slight association between 
diarrhea and lacteal dilation in the small bowel (P=0.0098), 
IBD in Cats and Dogs
Table 4. Histopathologic assessment of small and large bowels of cats with IBD
Intestine LD CD VEI SQ VS MF IEL LPI
Small bowel (n: 14) 9 10 6 6 2 14 14 14
Duodenum (14) 9 10 6 5 2 14 14 14
Large Bowel (n: 6) 3 4 2 4 1 3 6 6
Colon (6) 3 4 2 4 1 3 6 6
LD: Lacteal dilation; CD: Crypt dystention; VEI: Villous Epithelial Injury; SQ: desquamation; VS: Villous stunting; MF: Mucosal fibrosis; IEL: Intraepithelial 
lymphocytes; LPI: Lamina propria infiltrate
Table 5. Relation between samples and clinical signs in small and large bowel of IBD cats
Intestine Vomiting Diarrhea Anorexia Weight Loss Hematochezia Mucoid Feces
Small bowel (n: 14) 5 8 2 1 - -
Duodenum (14) 5 8 2 1 - -
Large Bowel (n: 6) 3 4 1 - 1 1
Colon (6) 3 4 1 - 1 1
Fig 1. a) Villi appear markedly distended, with mild mononuclear infiltration, interstitial oedema of the lamina 
propria and moderate lacteal dilation. Haematoxylin & Eosin x200, b) Mild-diff use mononuclear  infiltration 
into the lamina propria. Haematoxylin & Eosin, x100, c) Mononuclear infiltration and oedema of the lamina 
propria, and mild hyperplasia of crypts and lymphoid aggregates. Haematoxylin & Eosin x40, d) Distension of 
a crypt, filled with mucus, infl ammatory cells and cellular debris, and surrounded with attenuated epithelial 
cells, as well as mononuclear cell infiltration into the lamina propria. Haematoxylin & Eosin x100
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and diarrhea and desquamation in the large bowel 
(P=0.0213) of dogs with IBD. The results of this analysis are 
shown in Table 6 and Table 7, respectively. Concerning cats, 
the statistical analysis showed a high association between 
villous stunting (P=0.0066) and villous epithelial injury 
(P=0.0214) with anorexia. The results of this analysis are 
shown in Table 8, where the odds ratio with the confidence 
intervals is presented. No significant associations were 
identified among the rest of the lesions and clinical signs 
of dogs and cats affected with IBD. 
DISCUSSION
Literature defining clinical and histopathological indexes 
to value the activity of the chronic inflammatory bowel 
disease is scarce. Therefore, its assessment in dogs and cats 
is quite difficult. This is particularly important in cats with 
a diffuse enteric disease, which exhibits mixed bowel signs 
and requires biopsy of both the small and large intestines 
for diagnosis [7]. In our study, we included hospital records 
that comprised biopsies of the small and large bowel. 
Interestingly, most of the clinical signs observed in these 
animals were quite similar to other studies performed on 
IBD that used the Canine Inflammatory Bowel Disease 
Activity Index (CIBDAI) or the feline chronic enteropathy 
activity index (FCEAI) [1,7,15,17]. A previous study based its 
analysis on the intensity of different clinical signs [1]. How- 
ever, in our research, the intensity and degree of the disease 
was partially ignored, and focused on the presence or 
absence of injury, avoiding interpretative ambiguity among 
pathologists as has been suggested by WSAVA new 
guidelines [10]. These subjective elements that do not always 
represent the existing inflammatory burden can lead to 
discordance between the results of different surveys using 
CIBDAI or FCEAI as described in other reports [13-17]. 
In this study, there were correlation between clinical 
signs and some histopathologic scores. This association 
was positive for lacteal dilation, desquamation, villous 
epithelial injury, and villus stunting. Interestingly, there 
was no correlation between the intensity of intraepithelial 
lymphocytes, lamina propria infiltrate, and mucosal fibrosis 
with IBD clinical signs.
Lymphangiectasia in animals is assumed to be an acquired 
disease, and its etiology is generally idiopathic [3]. It may 
also result from any type of obstruction to lymph flow 
in the lacteals, mesenteric lymph vessels or nodes, most 
frequently secondary to inflammation [8,12]. In our series, 
lacteal dilatation was in correlation with diarrhea, but it 
is important to consider that this clinical sign has been 
associated with chronic diarrhea [15,18]. Nonetheless, other 
important parameters associated with dilated lacteals 
such as hypoalbuminemia could not be evaluated as a 
consequence of the retrospective nature of our study. 
Other important changes observed in the mucosal 
architecture such as desquamation correlated well with 
diarrhea. A recent study indicated that changes in mucosal 
architecture were related to the presence and severity of 
GI disease [13]. Nonetheless, further prospective studies 
are needed to properly evaluate the meaning of these 
correlations.
In this study, the severity of the lymphocytic infiltration 
in the lamina propria did not correlate with the intensity 
of clinical signs. Different studies have reported that 
characterize the extent and severity of the inflammatory 
infiltrate in intestinal biopsies from dogs and cats is a 
difficult task [12-15]. Hence, some authors suggest that the 
presence of increased numbers of lymphocytes deposited 
in the lamina propria and their contribution to the IBD 
process are better explained when the intestine is checked 
as a big picture [8]. Moreover, studies performed in dogs and 
cats with IBD did show a predominant proinflammatory 
cytokine upregulation in the inflamed colonic and duodenal 
mucosa in animals with lymphoplasmacytic colitis or 
enteritis as happens in people, although not correlations 
were done [13,19]. In the present study, many similarities 
between the inflammatory response in the small and large 
intestine of dogs and cats affected with IBD were observed. 
Comparable findings were described in other studies [10,11,14] 
that showed better clinical evaluation without doing a 
distinction between the upper or lower intestine. 
The histopathological lesions identified in the animals 
of this study showed significant fibrosis associated with 
major damage to the mucous membrane of the small and 
large intestine. Similar features were reported in a study 
done in the small intestine of animals with severe IBD [6]. 
Different circumstances can interfere with the histo-
pathologic interpretation of intestinal samples such as 
the correct area of the GI tract to be sampled, the quality 
of tissue samples analyzed, and the lack of consistency 
in interpretation of histopathologic changes among 
pathologists [13-15]. These circumstances led to the WSAVA 
GI Standardization Group to develop a histopathologic 
template to avoid these concerns, but even with this 
histopathologic scoring system, important variations have 
been observed in the diagnostic interpretation of intestinal 
samples since the above-mentioned method did not 
include evaluation of all intestinal segments. Therefore, in 
the present study, we extended its use to other sections 
of the GI tract, and interestingly, its use did not show 
significant differences in the evaluation of the intestinal 
samples done among pathologists. Identical results were 
obtained in a recent study performed in dogs using a 
similar scoring system [13].
In conclusion, the histopathologic scoring system used in 
this study provided important information on the extent of 
mucosal inflammation in the GI tract of dogs and cats with 
IBD. However, this work proposes that the evaluation of 
inflammatory bowel disease can be complicated, especially 
with the use of retrospective records of archived intestinal 
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biopsies and subjective clinical and histopathologic decisions. 
To perform better results, it is important to follow-up on 
the affected animals and to evaluate outcome factors as 
an accurate assessment of the health status of patients 
as suggest reports on human chronic disease [20]. All 
these premises would be of great help in the uniformity 
of a standard for the evaluation, and monitoring of the 
inflammatory bowel disease.
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